GS-5745: Phase I data

Data from a dose-expansion cohort of 40 patients with advanced, unresectable gastric cancer or gastroesophageal junction tumors in a

Read the full 191 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE